---
run_id: halo-evidence-vs-diagnosis-validation-v9-vanilla-08
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v9
benchmark_version: halo-evidence-vs-diagnosis-validation-v9-v1
model_condition: vanilla
run_number: 8
model_name: gemma-4-31b-it-mlx
model_id: gemma-4-31b-it-mlx
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 32768
max_tokens: 1024
seed: 801
prompt_source: condition packet (vanilla) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 61d771e2bff7fd2e18be1d2999d0f601760656e3e69b4622989ca7bffd3aff8e
source_packet: the frozen Advisor prompt alone, with no added material - see run-packet.md
source_packet_sha256: 61d771e2bff7fd2e18be1d2999d0f601760656e3e69b4622989ca7bffd3aff8e
condition_packet_sha256: 61d771e2bff7fd2e18be1d2999d0f601760656e3e69b4622989ca7bffd3aff8e
output_file: model-outputs/vanilla-08.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - vanilla (run 08)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v9-v1`, condition `vanilla`, run 8 of 8. Real local-model run: `gemma-4-31b-it-mlx` via lmstudio, seed 801, on the frozen condition packet.

## Output

I recommend the **Claim File Review**.

### The Recommendation
You should commit to the Claim File Review. Your current "success" is an illusion created by financial incentives (bundle pricing) and managerial vanity (ops managers using the tool for enablement rather than production). You have a critical "black box" problem: you know *that* users are abandoning the tool or using it incorrectly, but you don’t know *why*—whether it is a failure of the AI's logic, a failure of the UI to provide an audit trail (the "explainability" gap in health-liability), or a failure of the user's trust.

The Claim File Review is the only option that audits the **actual work product**. By analyzing whether suggestions were accepted, overridden, or rewritten, you move from "proxy metrics" (usage percentages) to "value metrics" (accuracy and utility). This provides the ground truth necessary to decide if DraftPath is a scalable product or a sophisticated demo that closes deals but fails to deliver value.

### The Strongest Reason Against It
The Claim File Review is slow, manual, and qualitatively "noisy" compared to the other options. While the Commercial Cleanroom provides immediate financial validation and the Usage Quality Sprint provides high-velocity data, the File Review requires tedious human auditing. By choosing this, you sacrifice the ability to quantitatively prove to the Board—via a controlled experiment—exactly how much of your expansion revenue is driven by product value versus sales discounting.

### The Evidence That Would Change My Mind
I would pivot to the **Commercial Cleanroom** if you discovered that your current pipeline of "intent" for next year is almost entirely dependent on the bundle-price incentive. If a cursory audit of the sales pipeline reveals that 80%+ of expansion leads are tied to the expiring discount, you no longer have a product-market fit problem; you have a pricing and packaging crisis. In that scenario, validating the technical utility of the tool is secondary to discovering if anyone is actually willing to pay full price for it.
